Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Baxter
Daiichi Sankyo
Teva
Express Scripts
McKinsey
QuintilesIMS
Cipla
Novartis
Federal Trade Commission

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062123

« Back to Dashboard

NDA 062123 describes WYAMYCIN E, which is a drug marketed by Wyeth Ayerst and is included in one NDA. Additional details are available on the WYAMYCIN E profile page.

The generic ingredient in WYAMYCIN E is erythromycin ethylsuccinate. There are one hundred and one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
Summary for 062123
Tradename:WYAMYCIN E
Applicant:Wyeth Ayerst
Ingredient:erythromycin ethylsuccinate
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrengthEQ 400MG BASE/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION;ORALStrengthEQ 200MG BASE/5ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
US Department of Justice
Healthtrust
Colorcon
Farmers Insurance
Federal Trade Commission
US Army
Express Scripts
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot